Atosivian 6.75 mg Injection belongs to a class of medications called ‘tocolytic agents. It is used in adult women from week 24 to week 33 of the pregnancy to delay the premature birth of the baby. Premature labour occurs when the cervix opens after week 20 but before week 37 of pregnancy as a consequence of regular contractions. Preterm labour can result in premature delivery.

Atosivian 6.75 mg Injection contains Atosiban, which works by weakening the contractions of the uterus. It also reduces the frequency with which contractions occur. It accomplishes this by inhibiting the function of oxytocin, a natural hormone in your body that causes uterine contractions.

A qualified healthcare professional will administer Atosivian 6.75 mg Injection . The common side effects are injection site reactions, feeling sick (nausea), being sick (vomiting), headache, feeling dizzy, hot flushes, fast heartbeat, low blood pressure, feeling dizzy or light-headed, and high blood sugar. These side effects usually go away without requiring any treatment. However, if these side effects persist or worsen, inform your doctor immediately.

Atosivian 6.75 mg Injection may not be suitable for everyone, so tell your doctor about any medical conditions you have, especially if you are less than 24 weeks pregnant, more than 33 weeks pregnant, or amniotic fluid loss (premature rupture of your membranes), or if you have completed 30 weeks of your pregnancy or more, if your unborn baby (foetus) has an abnormal heart rate, or if you have bleeding from your vagina. You should stop breastfeeding while you are given Atosivian 6.75 mg Injection .

Atosivian 6.75 mg Injection contains Atosiban, which belongs to a class of medications called ‘tocolytic agents. It works by delaying the contractions of the uterus. It also reduces the frequency with which contractions occur. It accomplishes this by inhibiting the function of oxytocin, a natural hormone in your body that causes uterine contractions. Thereby delaying the delivery, decreasing the risk of miscarriage, and preventing immature birth.

Atosivian 6.75 mg Injection should not be used if your unborn baby has died, you have or could have an infection of the uterus, your placenta is covering the birth canal, your placenta is detaching from the wall of your womb, or you or your unborn baby have any other conditions that make continuing your pregnancy dangerous. If any of the following apply to you or you are unsure, check your doctor before being given Atosivian 6.75 mg Injection . Also, let your doctor know about all your medical conditions and the medications you are taking.

Maternal pulse rate, blood pressure, and fetal heart rate (FHR) should be closely monitored while using Atosivian 6.75 mg Injection .